Carolina Regional Cancer Center

Summary

Carolina Regional Cancer Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Prostate Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Carolina Regional Cancer Center is involved with conducting 16 clinical trials across 8 conditions. There are 1 research doctors associated with this hospital, such as Frank A. Vicini.

Top PIs

Clinical Trials running at Carolina Regional Cancer Center

Prostate Cancer

Breast Cancer

Prostate Adenocarcinoma

Low Testosterone

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Recruiting

2 awards

Phase 3

30 criteria

Relugolix + Radiation

for Advanced-Stage Prostate Cancer

This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.

Recruiting

0 awards

Phase 2